We are live on ! Find out more
CCM

Carderock Capital Management Portfolio holdings

AUM $456M
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
+0.98%
1 Year Est. Return
+31.89%
3 Year Est. Return
+88.65%
5 Year Est. Return
+111.4%
10 Year Est. Return
+513.53%
AUM
$189M
AUM Growth
-$5.86M
Cap. Flow
-$6.37M
Cap. Flow %
-3.37%
Top 10 Hldgs %
29.08%
Holding
75
New
4
Increased
18
Reduced
49
Closed

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$693K
2
TSM icon
TSMC
TSM
+$379K
3
BDX icon
Becton Dickinson
BDX
+$229K
4
XEC
CIMAREX ENERGY CO
XEC
+$224K
5
PPG icon
PPG Industries
PPG
+$220K

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$1.41M
2
ROP icon
Roper Technologies
ROP
+$683K
3
AAPL icon
Apple
AAPL
+$598K
4
ECL icon
Ecolab
ECL
+$565K
5
NVO
Novo Nordisk
NVO
+$511K

Sector Composition

Rank Sector Weight
1 Technology 24.83%
2 Healthcare 24.12%
3 Industrials 11.35%
4 Consumer Discretionary 8.97%
5 Consumer Staples 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
1
Novo Nordisk
NVO
$208B
$6.08M 3.22%
225,970
-18,650
-8% -$511K
ACN icon
2
Accenture
ACN
$102B
$5.97M 3.16%
52,686
-1,725
-3% -$200K
DHR icon
3
Danaher
DHR
$137B
$5.73M 3.03%
84,408
-3,268
-4% -$214K
CHD icon
4
Church & Dwight Co
CHD
$23.4B
$5.46M 2.89%
106,128
-10,396
-9% -$502K
HSIC icon
5
Henry Schein
HSIC
$9.77B
$5.42M 2.87%
78,127
-7,390
-9% -$500K
IDXX icon
6
Idexx Laboratories
IDXX
$44.1B
$5.4M 2.86%
58,196
-1,916
-3% -$165K
AAPL icon
7
Apple
AAPL
$4.54T
$5.39M 2.85%
225,696
-24,048
-10% -$598K
ROP icon
8
Roper Technologies
ROP
$38.8B
$5.28M 2.79%
30,952
-3,907
-11% -$683K
INTU icon
9
Intuit
INTU
$86.5B
$5.19M 2.75%
46,486
-2,045
-4% -$214K
ECL icon
10
Ecolab
ECL
$78.1B
$5.04M 2.66%
42,450
-4,843
-10% -$565K
MA icon
11
Mastercard
MA
$502B
$4.96M 2.62%
56,302
-4,217
-7% -$403K
ADP icon
12
Automatic Data Processing
ADP
$106B
$4.59M 2.43%
49,997
-1,346
-3% -$119K
CMCSA icon
13
Comcast
CMCSA
$85B
$4.58M 2.42%
140,446
-2,998
-2% -$93.1K
MKC icon
14
McCormick & Company Non-Voting
MKC
$13.7B
$4.48M 2.37%
84,078
-6,770
-7% -$330K
FISV
15
Fiserv Inc
FISV
$28.8B
$4.48M 2.37%
82,442
-7,818
-9% -$402K
TMO icon
16
Thermo Fisher Scientific
TMO
$213B
$4.37M 2.31%
29,562
-545
-2% -$80.4K
TTC icon
17
Toro Company
TTC
$8.75B
$4.36M 2.31%
98,920
+2,066
+2% +$90.2K
APH icon
18
Amphenol
APH
$198B
$4.33M 2.29%
301,740
-8,908
-3% -$128K
NKE icon
19
Nike
NKE
$61.9B
$4.28M 2.27%
77,565
-2,720
-3% -$155K
ORLY icon
20
O'Reilly Automotive
ORLY
$72.9B
$4.04M 2.14%
223,620
-24,930
-10% -$441K
AMGN icon
21
Amgen
AMGN
$208B
$4.02M 2.13%
26,410
+4,459
+20% +$693K
SRCL
22
DELISTED
Stericycle Inc
SRCL
$3.83M 2.03%
36,810
-1,793
-5% -$192K
SBUX icon
23
Starbucks
SBUX
$120B
$3.42M 1.81%
59,945
+1,845
+3% +$105K
PPG icon
24
PPG Industries
PPG
$24.6B
$3.39M 1.8%
32,587
+2,013
+7% +$220K
KDP icon
25
Keurig Dr Pepper
KDP
$42.3B
$3.25M 1.72%
33,646
-947
-3% -$86.9K

Similar funds

Carderock Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Carderock Capital Management held 75 positions worth $189M, down 3% from $195M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Carderock Capital Management withdrew a net $6.37M in Q2 2016, reducing 49 holdings. Its largest reduction was Abbott, cutting an estimated $1.41M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carderock Capital Management opened a new position in CIMAREX ENERGY CO worth $239K.

  • Carderock Capital Management's largest Q2 2016 buy was CIMAREX ENERGY CO: 2,000 shares worth $239K.
  • Carderock Capital Management added most to Amgen in Q2 2016, an estimated $693K increase.
  • Carderock Capital Management's biggest Q2 2016 reduction was Abbott, cutting an estimated $1.41M.
  • Carderock Capital Management's ten largest holdings make up 29% of its $189M portfolio in Q2 2016.
  • Carderock Capital Management opened 4 new positions and closed 0 in Q2 2016.
  • Carderock Capital Management's portfolio value fell 3% quarter-over-quarter to $189M.

Based on Carderock Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.